T. Rowe Price Associates’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $791K | Buy |
|
|||||
|
2025
Q2 | $647K | Buy |
|
|||||
|
2025
Q1 | $441K | Sell |
|
|||||
|
2024
Q4 | $14.4M | Sell |
|
|||||
|
2024
Q3 | $87.9M | Buy |
|
|||||
|
2024
Q2 | $54.3M | Sell |
|
|||||
|
2024
Q1 | $80.7M | Buy |
|
|||||
|
2023
Q4 | $41.4M | Sell |
|
|||||
|
2023
Q3 | $40.4M | Sell |
|
|||||
|
2023
Q2 | $51M | Buy |
|
|||||
|
2023
Q1 | $49.2M | Buy |
|
|||||
|
2022
Q4 | $29.8M | Buy |
|
|||||
|
2022
Q3 | $367K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $245K | Sell |
|
|||||
|
2021
Q4 | $384K | Buy |
|